Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
#Synthetic Blood Substitutes And Blood Products Market Revenue Outlook: What CAGR Lies Ahead Through 2030?#_x000D_
The market for synthetic blood substitutes and blood products has witnessed rapid expansion in recent years. This market is projected to expand from $7.6 billion in 2025 to $8.81 billion in 2026, achieving a compound annual growth rate (CAGR) of 15.9%. The historic period’s growth can be attributed to several factors including blood donation shortages, the demand arising from trauma and surgery, risks associated with transfusion-transmitted infections, an increase in cardiovascular surgeries, and military medical requirements._x000D_
_x000D_
The synthetic blood substitutes and blood products market is projected for substantial expansion in the coming years, with its size expected to reach $15.7 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.6%. This anticipated growth is influenced by rising trauma cases, surgeries performed on an aging population, innovations in recombinant factors, the demand for universal blood substitutes, and investments in emergency preparedness. Throughout this forecast period, significant trends will include the development of oxygen-carrying blood substitutes, alternatives for emergency trauma, a reduction in dependence on donor blood, the introduction of extended shelf-life blood products, and their adoption in military and disaster medicine._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Synthetic Blood Substitutes And Blood Products Market Growth Momentum: What Factors Are Shaping Demand?#_x000D_
The increasing occurrence of long-term health conditions is anticipated to fuel the expansion of the synthetic blood substitutes and blood products market in the future. Chronic diseases are defined as enduring health issues that can be managed but not cured, often lasting over a year and requiring continuous medical attention. This surge in chronic disease prevalence stems from various factors, such as an aging demographic, unhealthy habits, and extended lifespans. Synthetic blood substitutes and blood products are crucial for managing chronic disease prevalence, as they tackle specific issues like blood loss, anemia, and organ dysfunction, frequently observed in individuals with chronic ailments. For example, data from March 2025, provided by the Office for Health Improvement & Disparities (OHID), a UK unit of the Department of Health and Social Care, showed that the prevalence of type 2 diabetes recorded by GPs in adults aged 17 and over in England was 7.0% in March 2024, marking an increase from 6.8% in March 2023. Consequently, the growing incidence of chronic diseases acts as a significant catalyst for the expansion of the synthetic blood substitutes and blood products market._x000D_
_x000D_
#Synthetic Blood Substitutes And Blood Products Market Segment Performance And Emerging Opportunities#_x000D_
The synthetic blood substitutes and blood products market covered in this report is segmented – _x000D_
_x000D_
1) By Type: Perfluorocarbon Based Product (PFC), Haemoglobin Based Oxygen Carrier, Synthetic Platelet, Recombinant Factor, Blood Expander_x000D_
2) By Application: Cardiovascular Diseases, Anaemia, Organ Transplant, Injury and Trauma, Other Applications_x000D_
3) By End-User: Hospitals And Clinics, Blood Banks, Other End users_x000D_
_x000D_
Subsegments:_x000D_
1) By Perfluorocarbon Based Product (PFC): Emulsion-Based Products, Non-Emulsion-Based Products _x000D_
2) By Haemoglobin Based Oxygen Carrier: Polymerized Hemoglobin-Based Products, Crosslinked Hemoglobin-Based Products _x000D_
3) By Synthetic Platelet: Platelet Substitutes, Platelet Aggregation Inhibitors _x000D_
4) By Recombinant Factor: Recombinant Factor VIII, Recombinant Factor IX, Other Recombinant Factors _x000D_
5) By Blood Expander: Colloid Solutions, Crystalloid Solutions_x000D_
_x000D_
#Synthetic Blood Substitutes And Blood Products Market Trends Redefining Industry Growth#_x000D_
Leading companies active in the synthetic blood substitutes and blood products market are concentrating on developing innovative products, such as lab-grown blood vessels. This focus aims to enhance emergency medical care, improve outcomes for trauma treatment, and address the global scarcity of donor blood and tissues. Lab-grown blood vessels are artificial blood conduits engineered from human or synthetic cells, designed to emulate the structure and function of natural arteries and veins for medical uses like trauma repair, dialysis, and cardiovascular surgery. For instance, in December 2024, Humacyte Global, Inc., a US-based clinical-stage biotechnology platform company, received US Food and Drug Administration (FDA) approval for Symvess. This off-the-shelf, bioengineered blood vessel implant is intended for trauma patients needing urgent revascularization, providing a safer option than vein harvesting or synthetic grafts. Symvess, developed for universal application, functions by restoring blood flow and preserving limbs after severe injuries._x000D_
_x000D_
#Synthetic Blood Substitutes And Blood Products Market Competitive Analysis Of Leading Industry Participants#_x000D_
Major companies operating in the synthetic blood substitutes and blood products market are Takeda Pharmaceutical Company Limited, Fresenius Kabi AG, Baxter International Inc., Octapharma AG, Green Cross Corporation, Alliance Pharmaceutical Corporation, Hemosol Inc., Sanguine Corporation, Sangart Inc., Biopure Corporation, Tenex Therapeutics, Velico Medical, Hemarina S.A., KaloCyte Inc., Aurum Biosciences Limited, SpheriTech Limited, Dendritech Inc., HbO2 Therapeutics LLC, HemoBioTech Inc., Somatogen Inc. _x000D_
_x000D_
#View The Full Synthetic Blood Substitutes And Blood Products Market Report:#_x000D_
_x000D_
#Synthetic Blood Substitutes And Blood Products Market Geographic Distribution And Regional Opportunities#_x000D_
North America was the largest region in the synthetic blood substitutes and blood products market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic blood substitutes and blood products market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.